Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) - Stock Prices, Stock Peers & Analysis

Home
688266.SS

Company Name	Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Symbol	688266.SS
Currency	CNY
Price	114.92
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	30,420,243,360
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	49 - 120.8
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Zelin Sheng
Website	https://www.zelgen.com

An error occurred while fetching data.

About Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers small molecule and recombinant protein drugs for the treatment of liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, nasopharyngeal carcinomas, myelofibrosis, hemorrhage, and hepatobiliary diseases. The company was